跳至主要内容
临床试验/NCT06933589
NCT06933589尚未招募不适用

Effect of a New Optimized Plant Ingredient on the Plant Protein of Seniors at Cardio-metabolic Risk - P-Probs Project

University Hospital, Clermont-Ferrand1 个研究点 分布在 1 个国家目标入组 10 人开始时间: 2025年5月14日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
10
试验地点
1
主要终点
Whole body protein metabolism

研究概览

简要总结

The aim of the study is to compare the use of amino acids in whole-body protein metabolism in elderly consumers at risk of metabolic syndrome, after ingestion of 2 foods differing only in the nature of their proteins (optimized blend of vegetable proteins versus milk proteins).

The protocol consists in studying the postprandial evolution of protein metabolism. Two products will be tested: one based on dairy proteins, the other on an optimized blend of vegetable proteins).

详细描述

Written consent will be obtained from subjects after they have been informed of the aims, nature and possible risks of the study.

Prior to inclusion, subjects will have a medical check-up carried out in the Nutritional Exploration Unit (UEN), including an interview about personal and family history and medication taken, as well as a standard medical examination and a blood test for a biological work-up (9.5 ml). Compliance with inclusion/exclusion criteria will be verified during this examination.

Subjects included in the study will come to the UEN to undergo the pre-study dietary visit and to complete the two study days of 9.5 hours each, at least two weeks apart.

For each study day, volunteers will arrive in the morning with an empty stomach. Two vascular catheters will be implanted. One catheter will provide continuous intravenous infusion of a labelled amino acid (13C Leucine) for a total duration of 9.5 hours. The second catheter will be used for blood sampling (8 ml), performed on an empty stomach and then, kinetically after ingestion of one of the two study products, in the form of food prepared on site. The IV-infused tracers will be used to monitor the kinetics of leucine appearance in plasma, and to quantify amino acid utilization flows at whole-body level (protein synthesis, degradation). Blood samples will also be taken to determine aminoacidemia, glycemia, insulinemia and plasma concentrations of hormones involved in regulating food intake (grelin, cholecystokinin, Glucagon-like-peptide-1 (GLP1), peptide YY (PYY).

Exhaled gases will be collected during the study days. Indirect calorimetry measurements lasting 20 minutes will be taken in the post-absorptive and post-prandial periods. Seven indirect calorimetry measurements will be taken on each study day. Finally, subjects will be asked to rate their satiety on a visual analog scale, at different times during the study days.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Basic Science
盲法
Single (Care Provider)

盲法说明

Participants will not know which protein ingredient is included in the test-meal.

入排标准

年龄范围
65 Years 至 —(Older Adult)
性别
Male
接受健康志愿者
是

入选标准

  • •Waist circumference > 94cm
  • •Triglycerides > 1.5 g/L or HDL cholesterol < 0.4 g/L
  • •Fasting blood glucose < 1.26g/L
  • •Biological profile considered compatible with study participation,
  • •Venous status judged satisfactory by the nurses, allowing catheter placement for the study,
  • •Individuals able to sign the informed consent form,
  • •Persons subject to a social security scheme.

排除标准

  • •Subjects on special diets (vegetarian, vegan, etc.),
  • •Subject showing a weight loss ≥ 5% in 1 month or ≥ 10% in 6 months compared to usual weight.
  • •Subject refusing to stop taking dietary supplements for the duration of the study,
  • •Subject refusing to consume any of the proposed products,
  • •Subject with food allergy(ies) to one or more components of the products under study, or with a contraindication to the consumption of these products,
  • •Subjects with a pathology or treatment (antidiabetics, hypolipidemics, corticoids, neuroleptics) judged by the investigator to be incompatible with the study,
  • •Subjects with dysthyroidism that has not been stabilized for at least 3 months,
  • •Subject with unstabilized hypertension for at least 3 months,
  • •Subject with a medical and/or surgical history deemed by the investigator to be incompatible with the trial,
  • •Subject having undergone surgery that could interfere with the study objectives (as judged by the investigating physician) in the 3 months preceding the study,
  • •Smoking > 5 cigarettes/day,
  • •Alcohol > 3 glasses/day,
  • •Claustrophobic subject,
  • •Person refusing to be registered with the French Ministry of Health's Fichier National des Volontaires Sains,
  • •Major under guardianship or with limited rights,
  • •Subject not affiliated to social security,
  • •Subject in a period of exclusion from a previous study or having received a total amount of compensation exceeding 6000 euros over the 12 months preceding the start of the trial (after verification in the Fichier des Volontaires pour la Recherche Biomédicale).

研究组 & 干预措施

Plant proteins

Experimental

Test meal incorporating an optimized plant protein ingredient

干预措施: Test meal with plant protein (Other)

Milk protein

Active Comparator

Test meal incorporating milk proteins

干预措施: Test meal with milk protein (Other)

结局指标

主要结局

Whole body protein metabolism

时间窗: 8 months (including mass spectrometry analysis and calculations)

Body leucine flux kinetics: oxidation, protein synthesis

次要结局

  • Satiety effect(12 months)
  • Evolution of blood parameters related to satiety(12 months)
  • Product tolerance(12 months)

研究者

发起方
University Hospital, Clermont-Ferrand
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验